Oral concurrent abstract sessions at #ISC25
Make time to take in these concurrent abstract sessions on Wednesday, Feb. 5, and Thursday, Feb. 6.
Wednesday, Feb. 5
Late-Breaking Science Oral Abstracts I
2 p.m. | Room 151
LBS5 | Volume of Brain Saved in Patients With a Medium Distal Vessel Occlusion Stroke Treated With Endovascular Therapy Plus Best Medical Treatment Versus Best Medical Treatment Alone: A Sub-Analysis of the DISTAL Trial
Aikaterini Anastasiou, University Hospital Basel, Basel, Switzerland
2:12 p.m. | Room 151
LBS6 | The SYCAMORE Study Results: First Randomized, Placebo-Controlled Phase 2 Trial in Symptomatic Cerebral Cavernous Malformation (CCM) Evaluating REC-994
Jan-Karl Burkhardt, Penn Medicine, Philadelphia, Pennsylvania
2:24 p.m. | Room 151
LBS7 | Efficacy and Safety of Minocycline in Patients With Acute Ischemic Stroke (EMPHASIS): A Randomized Control Trial
Yilong Wang, Beijing Tiantan Hospital, Beijing, China
2:36 p.m. | Room 151
LBS8 | Targeting Cerebral Amyloid Angiopathy at its Source: An Amyloid Beta Precursor Protein-Targeted siRNA Reduced Vascular Amyloid Beta and Hemorrhage in Rodent Models
Kirk Brown, Alnylam Pharmaceuticals, Inc., Massachusetts, Cambridge
Thursday, Feb. 6
Late-Breaking Science Oral Abstracts II
9:15 a.m. | Room 408AB
LBS9 | Clinical Benefit of Nerinetide at One Year in Early Window Participants Enrolled in ESCAPE-NEXT
Corey Adams, NoNO Inc., Toronto, Ontario, Canada
9:27 a.m. |Room 408AB
LBS10 | Impact of Socioeconomic Status on Quality and Clinical Outcomes in Acute Ischemic Stroke Patients: Findings From Get With The Guidelines®-Stroke
Kathie Thomas, American Heart Association, Grand Rapids, Michigan
9:39 a.m. | Room 408 AB
LBS11 | More Severe Disruption of the Blood-Brain Barrier Predicts Greater Progression of Cerebral Small Vessel Disease
Richard Leigh, Johns Hopkins University, Towson, Maryland
9:51 a.m. | Room 408 AB
LBS12 | Efficacy Of Otaplimastat in Acute Stroke Patients Requiring Reperfusion Therapy Standard of Care: A Pooled Analysis Of Two Double-Blind, Randomized, Placebo-Controlled Studies
Jong S. Kim, Gangneung Asan Hospital, Seoul, Korea (the Republic of)
10:03 a.m. | Room 408AB
LBS13 | Stability of Flow Diverter Braids In INSPIRE-A: Biomechanical Predictors and Clinical Relevance
Jens Fiehler, University Medical Center Hamburg, Hamburg, Germany
10:15 a.m. | Room 408 AB
LBS14 | The Efficacy of Papaverine to Prevent Radial Artery Spasm During Transradial Cerebral Angiography (PASS): A Multicenter Randomized Trial
Yamei Tang, Sun Yat-sen Memorial Hospital, Guangzhou, China
10:27 a.m. | Room 408 AB
LBS15 | Results of the First Randomized Controlled Trial of Intravenous Alteplase Initiated Within 4.5 Hours of Central Retinal Artery Occlusion (CRAO): The THEIA Study
Benoit Guillon, University Hospital, Nantes, France
Late-Breaking Science Oral Abstracts III
2 p.m. | Room 502 A
LBS21 | Efficacy and Safety of Intra-Arterial Thrombolysis Following Endovascular Reperfusion for Large-Vessel Occlusion Acute Ischemic Stroke: An Individual Patient Data Meta-Analysis of POST-UK and POST-TNK Randomized Trial
Wenjie Zi, Xinqiao Hospital, Choqi, China
2:12 p.m. | Room 502 A
LBS22 | Glucagon-Like Peptide-1 Receptor Agonist in Large Vessel Occlusion Stroke Treated by Reperfusion Therapy – A Randomized Trial
Bonaventure Yiu Ming Ip, The Chinese University of Hong Kong, Shatin, China
2:24 p.m. \ Room 502 A
LBS23 | Transauricular Vagus Nerve Stimulation Decreases Inflammatory Biomarkers and Affects NIHSS in Acute Ischemic Stroke Patients: Results From the NUVISTA Trial
Osvaldo Laurido-Soto, Washington University in St. Louis, Saint Louis, Missouri
2:36 p.m. | Room 502A
LBS24 | Emergency Stroke Unit for Acute Cerebrovascular Events: A Multicenter, Alternating-Week, Randomized, Controlled Trial
Yongjun Wang, Beijing Tiantan Hospital, CMU, Beijing, China
Late-Breaking Science Oral Abstracts IV
2 p.m. | Room 408AB
LB25 | Updated Results From the Multicentric, Randomized Study Of Sovateltide (Tycamzzi™) in Acute Cerebral Ischemic Stroke Patients
Anil Gulati, Pharmazz, Inc., Willowbrook, lllinois
2:12 p.m. | Room 408AB
LBS26 | Comparative Effectiveness of Direct Oral Anticoagulants and Warfarin in Reduced Ejection Fraction After Stroke (CEDAR)
Rami Morsi, University of Chicago, Chicago, Illinois
2:24 p.m. | Room 408AB
LBS27 | Dementia-Free Survival Differs by Midlife Blood Pressure and Genetic Risk Groups: The Atherosclerosis Risk in Communities (ARIC) Study
Valerie Morrill, NIH, Bethesda, Maryland
2:36 p.m. | Room 408AB
LBS28 | SPRIN2G-D Nomogram: A Reliable Tool to Predict the 90-day Unfavorable Prognosis in Minor Ischemic Stroke Patients Receiving Intravenous Thrombolysis
Huijuan Jin, Wuhan Union Hospital, Wuhan, China
Late-Breaking Science Oral Abstracts V
3:30 p.m. | Room 502A
LBS29 | Rapid Administration of Enteral Nutrition Reduces Complications and Is Non-Inferior to Conventional Administration in Acute Stroke Patients: The Rapid EN Randomized Clinical Trial
Kentaro Suzuki, Nippon Medical School, Tokyo, Japan
3:42 p.m. | Room 502A
LBS30 | Cerebral Blood Flow Response to Intrathecal Nicardipine Is Associated With Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
Ofer Sadan, Atlanta, Georgia
3:54 p.m. | Room 502A
LBS31 | Infarct Growth Rate and Tenecteplase Benefit in Ischemic Stroke at 4.5 to 24 Hours Without Thrombectomy: A Secondary Analysis of the TRACE-3 Trial
Yunyun Xiong, Beijing Tiantan Hospital, Beijing, China
4:06 p.m. | Room 502A
LBS32 | Spatio-Temporal Progression of Focal Ischemic White Matter Injury
Hung Nguyen, Oregon Health Science University, Portland, Oregon
Late-Breaking Science Oral Abstracts VI
4:45 p.m. | Room 502A
LBS33 | Increase in Acute Ambient Particulate Matter Before Stroke Is Associated With Deterioration in Early Stroke Outcomes
Kristina Shkirkova, Keck School of Medicine of USC, Los Angeles, California
4:57 p.m. | Room 502A
LBS34 | Identification of Potential Neuroprotective Drug Targets for Ischemic Stroke From Genetic Insights: A Mendelian Randomization Study
Xinyan Wang, Beijing Tiantan Hospital, CCMU, Beijing, China
5:09 p.m. | Room 502A
LBS35 | The EMBOLISE Observation Study: Embolization of the Middle Meningeal Artery With ONYXTM Liquid Embolic System in the Treatment of Subacute and Chronic Subdural HEmatoma
Jason Michael Davies, University at Buffalo, Buffalo, New York
5:21 p.m. | Room 502A
LBS36 | Central Nervous System Fibroblasts Mediate Extracellular Matrix Remodeling in Cerebral Amyloid Angiopathy
Kiersten Scott, UTHealth, Houston, Texas
